🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aim of the trial is to evaluate the safety and efficacy of sintilimab and p...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2021-09-01
Trial ID
NCT04676789
Treatments Being Tested
Response Rate...
Status
Completed
Location
University of Southern California
Start Date
2013-11-06
Trial ID
NCT01928576
Treatments Being Tested
This is a phase III, randomized, double-blinded, multicenter clinical study...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2018-12-20
Trial ID
NCT03866993
Treatments Being Tested
This phase I/II trial studies the side effects of a breast cancer vaccine (...
Status
Withdrawn
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2020-12-21
Trial ID
NCT04418219
The goal of this clinical trial is to investigate the efficacy, safety and ...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2023-07-04
Trial ID
NCT06424821
Treatments Being Tested
This is a multicenter, open-label, multiple dose, dose escalation phase I s...
Status
Completed
Location
Border Medical Oncology Research Unit
Start Date
2018-04-26
Trial ID
NCT03523819
This is a multi-center, open-label phase IIA study that investigates the pr...
Status
Recruiting
Location
University of California, Irvine
Start Date
2017-07-01
Trial ID
NCT03259867
Treatments Being Tested
This pilot phase 2 study evaluate the effectiveness and safety of pembroliz...
Status
Recruiting
Location
Saint Petersburg State University Hospital
Start Date
2024-03-25
Trial ID
NCT06374602
Treatments Being Tested
The goals of this study are to evaluate the clinical benefit and safety of ...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2016-04-07
Trial ID
NCT02760498
Treatments Being Tested
This will be a Phase Ib open-label trial of CAVATAK™ (CVA21) in combination...
Status
Unknown
Location
Austin Health
Start Date
2017-08-09
Trial ID
NCT02824965
Treatments Being Tested